Harbour Investments Inc. lessened its stake in shares of The Clorox Company (NYSE:CLX – Free Report) by 2.0% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 5,269 shares of the company’s stock after selling 109 shares during the period. Harbour Investments Inc.’s holdings in Clorox were worth $856,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also bought and sold shares of CLX. Brooklyn Investment Group raised its holdings in Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after acquiring an additional 95 shares in the last quarter. Prospera Private Wealth LLC acquired a new stake in shares of Clorox in the third quarter valued at approximately $27,000. Continuum Advisory LLC lifted its position in shares of Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after buying an additional 138 shares during the last quarter. Asset Planning Inc acquired a new stake in shares of Clorox in the fourth quarter valued at approximately $32,000. Finally, Halbert Hargrove Global Advisors LLC acquired a new stake in shares of Clorox in the fourth quarter valued at approximately $36,000. Institutional investors own 78.53% of the company’s stock.
Clorox Price Performance
Clorox stock opened at $145.33 on Thursday. The stock’s fifty day moving average price is $153.40 and its two-hundred day moving average price is $159.97. The Clorox Company has a one year low of $127.60 and a one year high of $171.37. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The firm has a market cap of $17.90 billion, a PE ratio of 39.71, a price-to-earnings-growth ratio of 2.62 and a beta of 0.45.
Clorox Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be paid a $1.22 dividend. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.36%. Clorox’s payout ratio is 133.33%.
Wall Street Analyst Weigh In
CLX has been the subject of a number of recent analyst reports. Wells Fargo & Company raised their price objective on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 4th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research report on Thursday, January 30th. Evercore ISI raised their price objective on Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. DA Davidson cut their price objective on Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research report on Wednesday, February 5th. Finally, JPMorgan Chase & Co. increased their target price on Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Three equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, Clorox has an average rating of “Hold” and a consensus target price of $159.62.
Check Out Our Latest Stock Analysis on Clorox
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading
- Five stocks we like better than Clorox
- Retail Stocks Investing, Explained
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Investing In Preferred Stock vs. Common Stock
- Alphabet’s Officially In A Bear Market—Time To Buy?
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- D-Wave and Quantum Supremacy: Implications For Investors
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.